World’s first pig liver transplant keeps man alive for 171 days in China

Published on March 27, 2026

In a historic medical achievement, a 71-year-old man in China has survived for 171 days with a genetically modified pig liver, marking the world’s first successful xenotransplantation of a pig organ. The groundbreaking procedure, which was meticulously detailed in recent medical reports, highlights the potential of xenotransplantation to address the growing shortage of human organs for transplantation.

The patient, who had been suffering from end-stage liver disease, received the transplant as a last resort after traditional treatment options were exhausted. Medical professionals utilized a specially engineered pig liver, which was designed to minimize the risk of rejection and enhance compatibility with the human immune system. This landmark surgery has provided crucial insights into the viability of using animal organs to supplement human ones, particularly in life-threatening situations.

Initial recovery and ongoing monitoring of the patient indicated that the pig liver performed its function remarkably well, sustaining the patient’s life for more than five months. During this period, the medical team closely observed how the patient’s body reacted to the foreign organ, gathering data that could inform future xenotransplantation efforts.

The success of this procedure not only raises hopes for patients currently on waiting lists for organ transplants but also elevates the discussion surrounding the ethical and practical considerations of using animal organs in human medicine. As the demand for organ transplants continues to outpace supply, innovations like this could provide a critical pathway to alleviate the crisis.

Experts in the field view this development as a pivotal moment in transplantation medicine. The insights gained could lead to more refined techniques in the future and potentially foster advancements that further improve the safety and efficacy of xenotransplantation.

As the medical community celebrates this advancement, attention will also turn to the regulatory frameworks and ethical implications surrounding the use of genetically modified animals in medical procedures. Ongoing research and clinical trials will be essential to ensure the long-term viability and safety of such pioneering treatments in mainstream healthcare.

Related News